Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12612001094864
Ethics application status
Approved
Date submitted
12/10/2012
Date registered
12/10/2012
Date last updated
8/03/2016
Type of registration
Retrospectively registered
Titles & IDs
Public title
Review of Management and Outcome of Women with Thrombophilia-Risk during Pregnancy at a Single Institution
Query!
Scientific title
Review of Management and Outcome of Women with Thrombophilia-Risk during Pregnancy at a Single Institution
Query!
Secondary ID [1]
281386
0
nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
VTE in Pregnancy
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Thrombophilia
287620
0
Query!
Pregnancy
287621
0
Query!
Condition category
Condition code
Blood
287949
287949
0
0
Query!
Haematological diseases
Query!
Reproductive Health and Childbirth
287950
287950
0
0
Query!
Other reproductive health and childbirth disorders
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
To study pregnant women at risk of thrombophilia who received anticoagulation therapy according to the Royal College of Obstetricians and Gynaecologists 2004 guidelines “Thromboprophylaxis During Pregnancy, Labour and after Vaginal Delivery” and compare their obstetric outcomes with a matched cohort of women without thrombophilia-risk.
The patients’ medical records will be reviewed by a trainee of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists and supervised by senior Obstetricians. All patients were co-managed by a haematologist who assessed the patients and determined the need for anticoagulation and the appropriate anticoagulant and regimen as per the Royal College of Obstetricians and Gynaecologists 2004 guidelines “Thromboprophylaxis During Pregnancy, Labour and after Vaginal Delivery” and its subsequent edition in 2009 “Green-top Guideline 37a”. The data will be collected from January 2007 to December 2010.
Query!
Intervention code [1]
285864
0
Not applicable
Query!
Comparator / control treatment
pregnant women without thrombophilia risk during the same period at the same institution.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
288158
0
To study pregnant women at risk of thrombophilia who received anticoagulation therapy according to the Royal College of Obstetricians and Gynaecologists 2004 guidelines Thromboprophylaxis During Pregnancy, Labour and after Vaginal Delivery and compare their obstetric outcomes with a matched cohort of women without thrombophilia-risk.
An assessment form was designed and used to collect medical, obstetric, and family history for each patient as well as risk factors for thrombosis and previous VTE. Outcomes of previous and current pregnancies were also recorded.
Query!
Assessment method [1]
288158
0
Query!
Timepoint [1]
288158
0
at the end of the study.
Query!
Secondary outcome [1]
299526
0
Nil
Query!
Assessment method [1]
299526
0
Query!
Timepoint [1]
299526
0
Nil
Query!
Eligibility
Key inclusion criteria
Pregnant women above the age of 18, that having risk for developing thrmboembolic events and underwent anticoagulation therapy during their pregnancy.
Query!
Minimum age
No limit
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
non-pregnant females are excluded and pregnant women without any thrombophilia-risk are not eligible as well.
Query!
Study design
Purpose
Screening
Query!
Duration
Longitudinal
Query!
Selection
Defined population
Query!
Timing
Retrospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
23/09/2009
Query!
Actual
15/01/2007
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
31/12/2010
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
40
Query!
Accrual to date
Query!
Final
38
Query!
Recruitment in Australia
Recruitment state(s)
TAS
Query!
Funding & Sponsors
Funding source category [1]
286137
0
Hospital
Query!
Name [1]
286137
0
Launceston General Hospital
Query!
Address [1]
286137
0
Charles Street,
Launceston, 7250
Tasmania
Query!
Country [1]
286137
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
Launceston General Hospital
Query!
Address
Charles Street,
Launceston, 7250
Tasmania
Query!
Country
Australia
Query!
Secondary sponsor category [1]
284949
0
None
Query!
Name [1]
284949
0
Query!
Address [1]
284949
0
Query!
Country [1]
284949
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
288189
0
Tasmania State wide Human Ethics Committee
Query!
Ethics committee address [1]
288189
0
University of Tasmania Private Bag 01 Hobart TAS 7001 Web: http://www.research.utas.edu.au/
Query!
Ethics committee country [1]
288189
0
Australia
Query!
Date submitted for ethics approval [1]
288189
0
Query!
Approval date [1]
288189
0
23/06/2009
Query!
Ethics approval number [1]
288189
0
H0010651
Query!
Summary
Brief summary
Pregnancy is associated with major physiological changes that affect coagulation and fibrinolytic system. An imbalance to this system leads to a hypercoaguable state and pregnant women are therefore at an increased risk of venous thromboembolic disease (VTE), especially if they are affected by an associated acquired or inherited thrombophilia. There are two factors that may exaggerate this risk; the high-risk nature of the thrombophilia and a history of a previous unprovoked VTE. High-risk hereditary thrombophilia include antithrombin deficiency, prothrombin gene mutation (PGM), and factor V leiden (FVL), while the presence of lupus anticoagulant or anticardiolipin antibodies are considered as acquired risk factors. Furthermore, homozygosity or presence of a combination of thrombophilia factors will aggravate the VTE-risk by certain fold increase. Apart from the occurrence of VTE, maternal thrombophilia has also been variably associated with an increased risk of early miscarriages, intrauterine growth restriction (IUGR), and pregnancy loss. Although it may seem intuitive to treat pregnant women with high-risk thrombophilia with anticoagulant prophylactically, there is a paucity of randomised trials in this area, and the balance of intervention versus conservative management should be carefully evaluated from both fetal and maternal point of view. Evidence-based guidelines have been published in an attempt to provide a more uniform clinical approach; however there appears to be a lack of consistency among different guidelines. The decision to recommend anticoagulant prophylaxis to women with thrombophilia is based on the risk-assessment or balance of bleeding versus VTE-risk as well as the potential effects of VTE and anticoagulant can have on pregnancy. However, the use of anticoagulant in pregnancy is challenging because of the potential for maternal and fetal complications. Despite this and the lack of controlled trials, there has been increased use of anticoagulants to prevent VTE and adverse pregnancy outcomes. In this retrospective/prospective study, the management strategies of women with high risk for thrombophilia who received antenatal care at a single institution during the period between Jan 2007 and December 2010 were reviewed and analysed.
Query!
Trial website
Query!
Trial related presentations / publications
Khalafallah AA, Ibraheem AR, Teo QY, Albarzan AM, Parameswaran R, Hooper E, Pavlov T, Dennis AE, Hannan T. Review of Management and Outcomes in Women with Thrombophilia Risk during Pregnancy at a Single Institution. ISRN Obstet Gynecol. 2014 Feb 17;2014:381826. doi: 10.1155/2014/381826. eCollection 2014. www.ncbi.nlm.nih.gov/pubmed/24693443 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945432/
Query!
Public notes
Query!
Contacts
Principal investigator
Name
34824
0
Prof Professor Alhossain Khalafallah
Query!
Address
34824
0
Launceston General Hospital
Charles Street
TAS
7250 Australia
Query!
Country
34824
0
Australia
Query!
Phone
34824
0
+61367776777
Query!
Fax
34824
0
Query!
Email
34824
0
[email protected]
Query!
Contact person for public queries
Name
18071
0
Professor Alhossain A. Khalafallah
Query!
Address
18071
0
Launceston General Hospital Charles Street, Launceston, TAS 7250
Query!
Country
18071
0
Australia
Query!
Phone
18071
0
+61373487111
Query!
Fax
18071
0
+61373487695
Query!
Email
18071
0
[email protected]
Query!
Contact person for scientific queries
Name
8999
0
Professor Alhossain A. Khalafallah
Query!
Address
8999
0
Launceston General Hospital Charles Street, Launceston, TAS 7250
Query!
Country
8999
0
Australia
Query!
Phone
8999
0
+61373487111
Query!
Fax
8999
0
+61373487695
Query!
Email
8999
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF